A federal board that regulates drug prices is unconstitutional and should be disbanded, says a manufacturer. Alexion Pharmaceuticals Inc. is challenging the legality of the Patented Medicine Prices Review Board in Federal Court: ‘They win this case, there won’t be a drug in Canada that is price-controlled’.
This content is for Blacklock’s Reporter members only. Please login to view this content. (Register here.)
